AstraZeneca Aims To Speed Drugs To China Market with New JV

 
• By Kevin Grogan

As the Chinese government looks to promote 'made in China' innovation, AstraZeneca has established a joint venture called Dizal Pharmaceuticals in tandem with a well-financed and influential local fund.

AZ_China
The signing ceremony in Nanjing to celebrate the launch of AZ's China JV • Source: AstraZeneca

More from China

More from Focus On Asia